Michael B. Atkins, MD, FASCO, on the Final Clinical Results From DREAMseq

Posted: Friday, June 6, 2025

Michael B. Atkins, MD, FASCO, of Georgetown Lombardi Comprehensive Cancer Center, reviews the final clinical results from the phase III DREAMseq trial of treatment sequences in BRAF V600–mutant metastatic melanoma (Abstract 9506).

---